Tolerance Bio Licenses NeoImmuneTech’s NT-I7 for Thymic Immune Restoration
Tolerance Bio licensed efineptakin alfa, also known as NT-I7, from NeoImmuneTech for certain thymus-related indications in the Americas and Europe. The clinical-stage long-acting IL-7 fusion protein has been evaluated in more than 800 participants…
